Αρχική World News Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers World News Nous-209 Efficiently Stimulates Immunity Against Neoantigens in Lynch Syndrome Carriers Από Ogkologos - 3 Φεβρουαρίου, 2026 336 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a phase Ib/II study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Husband Turns Wife’s Inspiring Poem for Her Daughters into a Book... 25 Φεβρουαρίου, 2020 Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with... 15 Μαΐου, 2024 Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients... 2 Δεκεμβρίου, 2024 EMA Recommends Extension of Indications for Amivantamab 6 Μαΐου, 2024 Φόρτωση περισσοτέρων HOT NEWS Sun Exposure Lowers Risk of Breast Cancer, Study Finds Molecular Profiling with Targeted Panel Tests that Includes Fusion Detection Has... ctDNA Monitoring Improves Early Relapse Detection After Treatment with Axicabtagene Ciloleucel... Dad Creates Inclusive Children’s Book For Daughter With Disability And Others...